BHV 1400
Alternative Names: BHV-1400Latest Information Update: 29 Nov 2023
At a glance
- Originator Biohaven Pharmaceuticals
- Class Antibodies
- Mechanism of Action Proteolysis
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical IgA nephropathy